Premium
Liver transplantation for patients with alcoholic hepatitis
Author(s) -
Artru Florent,
Louvet Alexandre,
Mathurin Philippe
Publication year - 2017
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.13248
Subject(s) - medicine , context (archaeology) , liver transplantation , alcoholic liver disease , economic shortage , transplantation , intensive care medicine , disease , liver disease , donation , cirrhosis , paleontology , linguistics , philosophy , government (linguistics) , economics , biology , economic growth
Alcoholic liver disease, considered as a self‐inflected disease, is an example of how moral judgment may affect ethical exercise of medicine which requires equity and fair utilization of a scarce resource in a context of organ shortage. Some consider that selection process should prioritize access to liver transplantation (LT) for patients who develop liver failure “through no fault of their own” even if limiting care because of a patient's perceived responsibility has been considered unethical. The absence of improvement after alcohol withdrawal, the high short‐term mortality risk and the poor predictability of the 6‐month rule in post‐LT relapse in alcohol consumption in AH patients not responding to medical therapy led to recommend an evaluation of LT. In the French‐Belgian pilot study, 26 patients with severe AH not responding to medical therapy underwent early LT (eLT). Stringent selection criteria were applied. Six‐month and 2‐year survivals of eLT patients were better than that of non‐transplanted matched controls: 77% vs 23% and 71% vs 23% respectively. Alcohol relapse occurred in 12% of patients after eLT. Three studies confirmed these results. The impact organ donation should be limited as showed by a recent survey and the efforts that should be made in public information campaigns based on scientific data and medical ethics. In conclusion, the ongoing accumulation of scientific evidence and requirement of ethical exercise of medicine lead to continue evaluating eLT as a therapeutic option in patients with severe AH not responding to medical therapy.